Skip to main content
. 2017 Mar 31;143(8):1585–1596. doi: 10.1007/s00432-017-2402-x

Table 4.

Most frequent all grades (≥10% in any group) nonhematological adverse events (AEs)

AEs Young (n = 243), n (%) Middle age (n = 494), n (%) Elderly (n = 300), n (%) Old (n = 52), n (%)
All grades Grade 3 or 4 All grades Grade 3 or 4 All grades Grade 3 or 4 All grades Grade 3 or 4
Abdominal pain 33 (13.6) 1 (0.4) 74 (15.0) 5 (1.0) 45 (15.0) 2 (0.7) 8 (15.4)
Rash 52 (21.4) 1 (0.4) 123 (24.9) 1 (0.2) 52 (17.3) 1 (0.3) 6 (11.5)
Pruritus 33 (13.6) 1 (0.4) 83 (16.8) 1 (0.2) 55 (18.3) 1 (0.3) 9 (17.3)
Fatigue 31 (12.8) 1 (0.4) 76 (15.4) 4 (0.8) 41 (13.7) 1 (0.3) 3 (5.8)
Headache 51 (21.0) 5 (2.1) 86 (17.4) 3 (0.6) 25 (8.3) 4 (7.7)
Nausea 19 (7.8) 2 (0.8) 59 (11.9) 35 (11.7) 3 (1.0) 10 (19.2)
Nasopharyngitis 36 (14.8) 44 (8.9) 31 (10.3) 2 (3.8)
Alopecia 25 (10.3) 1 (0.4) 59 (11.9) 24 (8.0) 7 (13.5)
Dry skin 17 (7.0) 43 (8.7) 30 (10.0) 3 (5.8)
Myalgia 26 (10.7) 1 (0.4) 52 (10.5) 19 (6.3) 1 (0.3) 2 (3.8)
Muscle spasm 13 (5.3) 48 (9.7) 30 (10.0) 2 (3.8)
Diarrhea 16 (6.6) - 39 (7.9) 1 (0.2) 35 (11.7) 1 (0.3) 4 (7.7)